Cost analysis of drug treatment in hypertensive patients at social security health care family medicine units
Objective. To estimate the increase of drug treatment costs associated with predictive factors of hypertensive patients in family medicine units. Materials and methods. A generalized linear model was employed to estimate costs with data from a microcosting costing study for a 1-year time horizon. So...
Saved in:
Main Authors: | Juan Figueroa-García (Author), Víctor Granados-García (Author), Ernesto Roldán-Valadez (Author), David Rojano-Mejía (Author), Jairo Enoc Cruz-Toledo (Author), Silvia Palomo-Piñón (Author) |
---|---|
Format: | Book |
Published: |
Instituto Nacional de Salud Pública,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute
by: Víctor Granados-García, et al.
Published: (2014) -
Clinical and treatment profiles of arterial hypertension in Mexico during the COVID-19 pandemic: a cross-sectional survey endorsed by the "Collaborative Group on Arterial Hypertension"
by: Silvia Palomo-Piñón, et al.
Published: (2024) -
The prevalence and treatment of hypertension in the elderly population of the Mexican Institute of Social Security
by: García-Peña Carmen, et al.
Published: (2001) -
Possible pharmacological interactions in hypertensive and/or diabetic elderly in family health units at Blumenau (SC)
by: Vicente Codagnone Neto, et al.
Published: (2010) -
Mexican ENARM: performance comparison of public vs. private medical schools, geographic and socioeconomic regions
by: Daniela Catherine Hernández-Gálvez, et al.
Published: (2019)